Hongyuan Pharma Sees Surge in Trading, Capital Inflows Boost Growth Outlook
Hongyuan Pharma’s high‑growth stock sees record trading and new biotech inflows—find out how rising liquidity and sector shifts could reshape its valuation and prospects.
4 minutes to read